Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narendra Kale

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 20, 2022
Circulating tumor cells as a predictor for poor prognostic factors and overall survival in treatment naïve oral squamous cell carcinoma patientsBurhanuddin Qayyumi, Atul Bharde, Gourishankar Aland, et al.
Diabetes, Obesity & Metabolism|February 14, 2025
Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in IndiaRakesh Sahay, Dinesh Gangwani, Manish Singh, et al.
Journal of Medical Virology|March 27, 2026
Association of Viraemic Phase Viral Load, Antibody Responses, and Immune Biomarkers With Severe DengueKalichamy Alagarasu, Yogesh K Gurav, Anisha Pulinchani, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|May 20, 2022
Circulating tumor cells as a predictor for poor prognostic factors and overall survival in treatment naïve oral squamous cell carcinoma patientsBurhanuddin Qayyumi, Atul Bharde, Gourishankar Aland, et al.
Diabetes, Obesity & Metabolism|February 14, 2025
Fixed dose combination of dapagliflozin, glimepiride and extended-release metformin tablets in patients with type 2 diabetes poorly controlled by metformin and glimepiride: A phase III, open label, randomized clinical study in IndiaRakesh Sahay, Dinesh Gangwani, Manish Singh, et al.
Journal of Medical Virology|March 27, 2026
Association of Viraemic Phase Viral Load, Antibody Responses, and Immune Biomarkers With Severe DengueKalichamy Alagarasu, Yogesh K Gurav, Anisha Pulinchani, et al.
Pageof 3